NLNG unveils GenScan AI to reduce MRI scan time
by Moronfolu Adeyemi · The Eagle OnlineNigeria LNG Limited (NLNG) has unveiled GenScan AI, an artificial intelligence-powered medical imaging innovation with the potential to reduce magnetic resonance imaging (MRI) scan times by up to 90 per cent while maintaining or improving image quality.
NLNG Manager, Corporate Communications and Public Affairs, Anne-Marie Palmer-Ikuku, disclosed this in a statement on Tuesday following the presentation of the innovation to stakeholders in Abuja.
GenScan AI was developed by Mary-Brenda Akoda, who won the 2026 Nigeria Prize for Science and Innovation sponsored by NLNG with the innovation.
According to the statement: “the innovation uses the C-MORE algorithm to reconstruct MRI images through a one-step framework, potentially reducing scan acquisition times by up to 90 per cent without requiring new MRI hardware.”
The technology could allow healthcare providers to examine more patients, shorten waiting periods and make better use of existing MRI equipment, particularly in areas where access to advanced diagnostic services remains limited.
Speaking at the presentation, NLNG General Manager, External Relations and Sustainable Development, Sophia Horsfall, said the company’s interest extended beyond recognising scientific achievement to ensuring that research produced practical benefits.
Horsfall said: “Our interest goes beyond recognising an outstanding idea.
“We want to see scientific research make a practical difference in people’s lives.”
She added: “GenScan AI offers the prospect of faster medical imaging and better use of existing equipment.
“This presentation creates an opportunity to discuss what is needed to move that promise towards practical application.”
Horsfall also stressed the importance of accurate diagnosis to effective treatment, noting that medical imaging provides evidence that helps healthcare professionals identify conditions and make informed decisions on patient care.
A member of the Prize’s Advisory Board, Professor Barth Nnaji, said GenScan AI stood out because of the quality of its science and its potential to address a practical healthcare challenge.
Nnaji said engagement with clinicians and other stakeholders would be necessary to determine how the innovation could be deployed safely and effectively.
He added that the Abuja presentation provided an opportunity to examine both the technology’s potential and what would be required for further development and eventual application.
Akoda emerged as the 2026 winner from 237 entries submitted under the theme, “Innovations in Artificial Intelligence, ICT and Digital Technologies for Development.”
Her selection followed an independent assessment by the Panel of Judges, chaired by Dr Omobola Johnson, and subsequent endorsement by the Advisory Board.
She became the first woman and first millennial to win the Prize as an individual recipient and is scheduled to receive the US$100,000 award at the Grand Award Night on October 9, 2026.
The unveiling comes amid efforts to improve access to timely and accurate diagnostic services in Nigeria, where advanced medical equipment and specialised healthcare services remain unevenly distributed.
Also Read
- Lionel Messi set for final Argentina appearance against Benin
- NLNG unveils GenScan AI to reduce MRI scan time
- Why Ndidi, Onyedika, five others withdrew from Super Eagles squad – NFF
- Mutilated corpse of unidentified man found behind market in Plateau
- 2027: Reps ask INEC to disqualify candidates not in submitted party registers
MRI is widely used to diagnose conditions affecting the brain, spine, joints and internal organs, but the examinations can take considerable time. The cost of acquiring and maintaining MRI equipment can also limit access.
An innovation capable of shortening scan times without the need for new hardware could help healthcare facilities make more efficient use of scanners already available and potentially increase the number of patients examined.
However, GenScan AI would require further testing and validation before moving from research into routine clinical use. Engagement with clinicians and other stakeholders would also be necessary to establish its safety, reliability and suitability for different diagnostic applications.
The Abuja presentation was therefore aimed at connecting the research with healthcare professionals and institutions that could help assess its prospects for practical deployment.
The Nigeria Prize for Science and Innovation, sponsored by NLNG, recognises scientific research and innovations with the potential to address practical development challenges in Nigeria.
The 2026 edition focused on artificial intelligence, information and communication technology and digital technologies, reflecting the expanding use of emerging technologies across sectors, including healthcare.
The public presentation of GenScan AI is expected to advance discussions on how the innovation can be developed, validated and potentially deployed to improve the efficiency of medical imaging services in Nigeria.
[wpadcenter_ad id='745970' align='none']